Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000899243-15-005095

S.V.P., General Counsel sold 1,129 shares at $6.32 ($7,135)

From the SEC's structured data for this filing

Trades in this filing

Ozeroff Christopher David · S.V.P., General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-09-18 Sale : show line 1 in the form −1,129 $6.32 $7,135 20,409 D
Open-market sales · 1,129 sh · avg $6.32 · $7,135
Loading xslF345X03/doc4.xml…